➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

MEN'S ROGAINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Men's Rogaine, and when can generic versions of Men's Rogaine launch?

Men's Rogaine is a drug marketed by Johnson And Johnson and is included in one NDA.

The generic ingredient in MEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

US ANDA Litigation and Generic Entry Outlook for Men's Rogaine

A generic version of MEN'S ROGAINE was approved as minoxidil by WATSON LABS on March 3rd, 1987.

  Start Trial

Summary for MEN'S ROGAINE
Drug patent expirations by year for MEN'S ROGAINE
Recent Clinical Trials for MEN'S ROGAINE

Identify potential brand extensions & 505(b)(2) entrants

University of Minnesota - Clinical and Translational Science InstitutePhase 2
The Skin of Color SocietyPhase 4
Wake Forest University Health SciencesPhase 4

See all MEN'S ROGAINE clinical trials

Paragraph IV (Patent) Challenges for MEN'S ROGAINE
Tradename Dosage Ingredient NDA Submissiondate
MEN'S ROGAINE AEROSOL, FOAM;TOPICAL minoxidil 021812 2009-04-06
WOMEN'S ROGAINE AEROSOL, FOAM;TOPICAL minoxidil 021812 2009-04-06

US Patents and Regulatory Information for MEN'S ROGAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Johnson And Johnson MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-001 Jan 20, 2006 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.